Dermavant Sciences, Inc., a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for dermatological conditions. Founded in 2014, Dermavant has rapidly established itself in the dermatology industry, with a commitment to addressing unmet medical needs through advanced research and development. The company’s core products include unique topical treatments that leverage cutting-edge science to enhance patient outcomes. Dermavant's flagship product, a novel formulation for psoriasis, exemplifies its dedication to delivering effective solutions that improve the quality of life for patients. With a strong market position, Dermavant has achieved significant milestones, including successful clinical trials and strategic partnerships that bolster its operational reach across North America and beyond. As a pioneer in dermatological innovation, Dermavant Sciences continues to shape the future of skin health.
We don't have data for Dermavant Sciences, Inc., but we can show you information about their parent organization instead.
View parent company